Darwin Global Management, Ltd.

Entity
Company
Business address
Whiteley Chambers, Don Street, JE2 4TR St. Helier, Jersey
Phone
(212) 729-7524
State of incorporation
Jersey
Fiscal year end
December 31
Signature 13F
Sarah Monime - Chief Compliance Officer
Signature Schedule 13D/G
Darwin Global Management, Ltd. - John Legge, Director and Chief Financial Officer
Signature Ownership
Darwin Global Management, Ltd. By: /s/ John Legge, Director and Chief Financial Officer
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Darwin Global Management, Ltd. has filed 36 SEC EDGAR filings since 2/16/2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
N-PX Open Document Open Filing Sep 2, 2025 Jun 30, 2025 028-21006
13F-HR Open Document Open Filing Aug 14, 2025 Jun 30, 2025 028-21006
SCHEDULE 13G/A Open Document Open Filing May 15, 2025
13F-HR Open Document Open Filing May 15, 2025 Mar 31, 2025 028-21006
13F-HR Open Document Open Filing Feb 14, 2025 Dec 31, 2024 028-21006
SCHEDULE 13G/A Open Document Open Filing Feb 14, 2025
SC 13G/A Open Document Open Filing TG THERAPEUTICS, INC Nov 14, 2024
13F-HR Open Document Open Filing Nov 14, 2024 Sep 30, 2024 028-21006
SC 13G Open Document Open Filing Sep 3, 2024
13F-HR Open Document Open Filing Aug 14, 2024 Jun 30, 2024 028-21006
N-PX Open Document Open Filing Jul 30, 2024 Jun 30, 2024 028-21006
13F-HR Open Document Open Filing May 15, 2024 Mar 31, 2024 028-21006
13F-HR Open Document Open Filing Feb 14, 2024 Dec 31, 2023 028-21006
SC 13G/A Open Document Open Filing TG THERAPEUTICS, INC. Feb 14, 2024
13F-HR Open Document Open Filing Nov 14, 2023 Sep 30, 2023 028-21006
13F-HR Open Document Open Filing Aug 14, 2023 Jun 30, 2023 028-21006
4 Open Document Open Filing Jun 28, 2023 Jun 27, 2023 001-40505
SC 13D/A Open Document Open Filing AMBRX BIOPHARMA INC. Jun 28, 2023
SC 13D/A Open Document Open Filing AMBRX BIOPHARMA INC. May 25, 2023
13F-HR Open Document Open Filing May 15, 2023 Mar 31, 2023 028-21006
SC 13G Open Document Open Filing TG THERAPEUTICS, INC. Apr 3, 2023
4 Open Document Open Filing Mar 8, 2023 Feb 27, 2023 001-40505
3 Open Document Open Filing Mar 8, 2023 Jan 1, 2023 001-40505
SC 13D Open Document Open Filing AMBRX BIOPHARMA INC. Mar 8, 2023
13F-HR Open Document Open Filing Feb 14, 2023 Dec 31, 2022 028-21006
SC 13G/A Open Document Open Filing AMBRX BIOPHARMA INC. Feb 14, 2023
SC 13G Open Document Open Filing Dec 19, 2022
13F-HR Open Document Open Filing Nov 14, 2022 Sep 30, 2022 028-21006
13F-HR Open Document Open Filing Aug 15, 2022 Jun 30, 2022 028-21006
13F-HR Open Document Open Filing May 16, 2022 Mar 31, 2022 028-21006
13F-HR Open Document Open Filing Feb 14, 2022 Dec 31, 2021 028-21006
13F-HR Open Document Open Filing Nov 15, 2021 Sep 30, 2021 028-21006
SC 14D9 Open Document Open Filing ACCELERON PHARMA INC. Oct 20, 2021
13F-HR Open Document Open Filing Aug 16, 2021 Jun 30, 2021 028-21006
13F-HR Open Document Open Filing May 17, 2021 Mar 31, 2021 028-21006
13F-HR Open Document Open Filing Feb 16, 2021 Dec 31, 2020 028-21006